Nitric oxide: A new possible biomarker in heart failure? Relationship with pulmonary hypertension secondary to left heart failure

Clin Investig Arterioscler. 2017 May-Jun;29(3):120-126. doi: 10.1016/j.arteri.2016.12.002. Epub 2017 Apr 5.
[Article in English, Spanish]

Abstract

Heart failure (HF) is a growing medical problem and it is of interest to study new biomarkers for better characterisation. In this sense, nitric oxide, reactive oxygen species (ROS), NADPH, and superoxide dismutase (SOD) were evaluated, along with their possible predictive value in patients with HF. An analysis was also performed on the potential differences between patients with and without secondary pulmonary hypertension (SPH), considered to have a worse prognosis. A significant decrease of nitric oxide and SOD was noted in HF, whereas ROS and NADPH were increased. These results agree with the pathophysiological changes characteristic of HF. It was also demonstrated that in patients with HF and SPH that nitric oxide and SOD were decreased when compared to HF without SPH, whereas ROS and NADPH were increased. Therefore, our results suggest that nitric oxide, ROS, NADPH, and SOD, could be considered as possible markers in HF, and could also characterise patients with SPH.

Keywords: Biomarcadores; Biomarkers; Heart failure; Hipertensión pulmonar; Insuficiencia cardíaca; Pulmonary hypertension.

MeSH terms

  • Animals
  • Biomarkers / metabolism
  • Heart Failure / complications
  • Heart Failure / physiopathology*
  • Humans
  • Hypertension, Pulmonary / etiology*
  • Hypertension, Pulmonary / physiopathology
  • NADP / metabolism
  • Nitric Oxide / metabolism*
  • Prognosis
  • Reactive Oxygen Species / metabolism
  • Superoxide Dismutase / metabolism

Substances

  • Biomarkers
  • Reactive Oxygen Species
  • Nitric Oxide
  • NADP
  • Superoxide Dismutase